Potency of CAR T-Cell Therapy for Myeloma May Vary by Disease Stage

CAR T cells are a more effective therapy if manufactured for patients with multiple myeloma prior to the onset of relapsed or refractory disease.

Source: CancerNetwork - October 7, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news